register

News & Trends - MedTech & Diagnostics

B. Braun launches renal care centres in NSW and QLD

Health Industry Hub | May 13, 2021 |

MedTech News: B. Braun, one of the world’s leading providers of medical devices, dialysis products and renal care services has opened two new haemodialysis centres.

The new facilities located in New South Wales and Queensland are the latest additions to over 350 B. Braun renal care clinics caring for almost 30,000 patients around the world.

The first new renal care centre in Gregory Hills, New South Wales, will allow B. Braun to provide quality renal care to Campbelltown community.  Located in close proximity to the Campbelltown Public Hospital, will have capacity to provide for up to 64 patients with haemodialysis treatment per week over two shifts. 

The second new haemodialysis unit in Morayfield, Queensland, located 46 km north of Brisbane is part of the Morayfield Health Hub. The new facility will support patients and the renal care needs of the local community. The Morayfield facility will have capacity to provide clinical care for up to 68 patient per week over two shifts.

Russ Hoskins, Division Head of Renal Care Centres, B. Braun Australia, said “With more than 40 years of experience in haemodialysis treatment, B. Braun is strongly committed to providing high quality renal care close to our patients. Our topmost priority remains always the well-being of our customers. We want to make sure that everyone who is in our care, feels comfortable and receives life-enriching healthcare through clinical excellence and evidence based practice.”

Both the facilities are equipped with the latest dialysis machine technology – the Dialog iQ. The new system is designed with two inputs to give improved information on the patient’s hemodynamic condition. Dialog iQ’s system intelligence is able to extrapolate data from multiple information sources and take the appropriate action based on the patient’s individual needs.

Back in 2018, B. Braun also acquired Diaverum renal care centres in Australia and New Zealand to expand their footprint.


News & Trends - Pharmaceuticals

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Clinicians shift stance, join calls for PBS subsidy of obesity and weight-loss medicines

Health Industry Hub | March 14, 2025 |

Over a third of Australian adults live with obesity, and the National Obesity Strategy estimates the direct and indirect costs […]

More


News & Trends - Pharmaceuticals

Astellas secures new indication for prostate cancer drug

Astellas secures new indication for prostate cancer drug

Health Industry Hub | March 14, 2025 |

Astellas Xtandi (enzalutamide) is now TGA registered for a new indication for patients with non-metastatic hormone-sensitive prostate cancer (nmHSPC) with […]

More


News & Trends - MedTech & Diagnostics

Stakeholder calls intensify as government stalls on genetic discrimination ban

Stakeholder calls intensify as government stalls on genetic discrimination ban

Health Industry Hub | March 14, 2025 |

Calls have intensified for the federal government to honour its commitment to outlaw genetic discrimination in life insurance, as stakeholders […]

More


News & Trends - MedTech & Diagnostics

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Pressure mounts to expand home-based therapies in kidney disease: World Kidney Day

Health Industry Hub | March 13, 2025 |

As Australia marks World Kidney Day, the stark reality is that one in three adults is at risk of chronic […]

More


This content is copyright protected. Please subscribe to gain access.